Skip to content

Scot Meyer

FTI says online retail sales to hit $1.2 Trillion

FTI says online retail sales to hit $1.2 Trillion

U.S. online retail sales will reach $1.2 trillion in 2024, up nearly 10% from last year, according to FTI Consulting’s 2024 Online Retail Report. The firm’s Retail & Consumer Products practice, which conducted analysis for the report, expects U.S. e-commerce sales to account for 22.

Stop & Shop to close 32 underperforming stores

Stop & Shop to close 32 underperforming stores

Stop & Shop said Friday that it will close 32 underperforming stores by year-end. The closures will leave the Ahold Delhaize chain with more than 350 stores across its five-state footprint. “Stop & Shop is proud of the deep roots and community ties we have developed as a neighborhood grocer of more

NRF: Back-to-school shopping has already begun

NRF: Back-to-school shopping has already begun

WASHINGTON – More than half (55%) of back-to-school and college shoppers have already begun buying items for the upcoming school year, according to the annual survey released today by the National Retail Federation and Prosper Insights & Analytics.

Dollar General extends Feeding America Partnership

Dollar General extends Feeding America Partnership

Dollar General has extended its partnership with Feeding America for a fourth year, pledging an additional $1 million to support the organization’s efforts to address food insecurity. Dollar General says food insecurity currently affects about 44 million Americans.

WBA appoints Dr. William Shrank to board

WBA appoints Dr. William Shrank to board

Walgreens Boots Alliance (WBA) today announced the appointment of Dr. William Shrank to the company’s board of directors. Dr. Shrank is globally recognized for his leadership and expertise in health care strategy, policy and population health.

WSJ: FTC plans to sue PBMs over insulin prices

WSJ: FTC plans to sue PBMs over insulin prices

The U.S. Federal Trade Commission is planning to sue UnitedHealth, Cigna and CVS Health — the three largest pharmacy-benefit managers — over their tactics for negotiating prices for drugs including insulin, the Wall Street Journal reported today.